Inogen sees revenue growth, but stock declines after report

Inogen, a Goleta-based medical device company specializing in portable oxygen concentrators, is starting to see its core business come back from the pandemic, and the company highlighted double-digit year-over-year growth in both earnings and revenue in its second quarter financial results, released Aug. 4. The company more than doubled its net income for the quarter Read More →
Amgen reports Q2 earnings decline

Amgen saw a 73% decline in net earnings in the second quarter of 2021, the company announced Aug. 3. Thousand Oaks-based Amgen, one of the world’s largest biotechnology companies, reported earnings per share of 81 cents for the quarter ended June 30, down from $3.05 per share in the same quarter last year. According to Read More →

Our View: Vaccines are the way out of this COVID resurgence
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Opinion: How to turn the next crisis into something routine
By Angel Iscovich We are just emerging from a once-in-a-generation crisis. COVID-19 has disrupted not just nations, but the world. We can view events as Pre-Pandemic and Post-Pandemic. To say the coronavirus has also disrupted businesses would be the understatement of the year. Or decade. We have witnessed the destruction of companies and industries that Read More →
Opinion: When it comes to vaccines, trust the real experts
By Frank Kalman When it comes to facing a deadly disease, who you are relying on for advice truly matters! According to Dr. Philip Landrigan — epidemiologist and pediatrician and one of the world’s leading advocates of children’s health — children today live longer, healthier lives and suffer less disease than children at any previous Read More →